What it is & what it does
Ceramide EOS is a specialised barrier lipid associated with the highly organised fat layers of the stratum corneum. It has an important structural role in maintaining an effective outer-skin barrier.
Not all ceramides have the same structure. Ceramide EOS belongs to the acylceramide family: EO refers to an esterified omega-hydroxy fatty-acid structure, while S denotes sphingosine. These distinctive long-chain lipids are involved in the organisation of protective layers in the stratum corneum and the corneocyte lipid envelope.
This makes EOS particularly interesting in barrier science. When the outer-skin lipid architecture is disturbed, skin can feel dry, tight or more reactive. Topical ceramides are used in moisturizing formulas to support the lipid environment, but results depend on whether the ingredients are properly formulated and delivered rather than simply listed on the label.
SESH Triple Dose contains Ceramide EOS alongside NS, NP, AP and EOP, as well as cholesterol and hydrating ingredients. Their roles are complementary to the formula's retinoids: ceramides are barrier lipids, not resurfacing actives. This combination explains the formulation approach; it does not by itself prove a measured reduction in water loss or a clinical barrier-repair outcome for the finished serum.
This makes EOS particularly interesting in barrier science. When the outer-skin lipid architecture is disturbed, skin can feel dry, tight or more reactive. Topical ceramides are used in moisturizing formulas to support the lipid environment, but results depend on whether the ingredients are properly formulated and delivered rather than simply listed on the label.
SESH Triple Dose contains Ceramide EOS alongside NS, NP, AP and EOP, as well as cholesterol and hydrating ingredients. Their roles are complementary to the formula's retinoids: ceramides are barrier lipids, not resurfacing actives. This combination explains the formulation approach; it does not by itself prove a measured reduction in water loss or a clinical barrier-repair outcome for the finished serum.
